Update on N6‐methyladenosine methylation in obesity‐related diseases
C Cheng, F Yu, G Yuan, J Jia - Obesity, 2024 - Wiley Online Library
Obesity is a chronic metabolic disease that is closely related to type 2 diabetes mellitus,
cardiovascular diseases, nonalcoholic fatty liver disease, obstructive sleep apnea, and …
cardiovascular diseases, nonalcoholic fatty liver disease, obstructive sleep apnea, and …
[HTML][HTML] Roles of RNA methylations in cancer progression, autophagy, and anticancer drug resistance
H Jo, K Shim, D Jeoung - International Journal of Molecular Sciences, 2023 - mdpi.com
RNA methylations play critical roles in RNA processes, including RNA splicing, nuclear
export, nonsense-mediated RNA decay, and translation. Regulators of RNA methylations …
export, nonsense-mediated RNA decay, and translation. Regulators of RNA methylations …
Research progress of human key DNA and RNA methylation-related enzymes assay
T Ma, Q Zhang, S Zhang, D Yue, F Wang, Y Ren… - Talanta, 2024 - Elsevier
Gene methylation-related enzymes (GMREs) are disfunction and aberrantly expressed in a
variety of cancers, such as lung, gastric, and pancreatic cancers and have important …
variety of cancers, such as lung, gastric, and pancreatic cancers and have important …
[HTML][HTML] Dissecting the effects of METTL3 on alternative splicing in prostate cancer
Although the role of METTL3 has been extensively studied in many cancers, its role in
isoform switching in prostate cancer (PCa) has been poorly explored. To investigate its role …
isoform switching in prostate cancer (PCa) has been poorly explored. To investigate its role …
[HTML][HTML] The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
X Zhou, K Chai, H Zhu, C Luo, X Zou, J Zou, G Zhang - BMC cancer, 2024 - Springer
The incidence of prostate cancer (PCa), the most prevalent malignancy, is currently at the
forefront. RNA modification is a subfield of the booming field of epigenetics. To date, more …
forefront. RNA modification is a subfield of the booming field of epigenetics. To date, more …
[HTML][HTML] The role of RNA modification in urological cancers: mechanisms and clinical potential
X Zhou, H Zhu, C Luo, Z Yan, G Zheng, X Zou, J Zou… - Discover Oncology, 2023 - Springer
RNA modification is a post-transcriptional level of regulation that is widely distributed in all
types of RNAs, including mRNA, tRNA, rRNA, miRNA, and lncRNA, where N6 …
types of RNAs, including mRNA, tRNA, rRNA, miRNA, and lncRNA, where N6 …
[HTML][HTML] METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor
X Chen, M Wang, H Wang, J Yang, X Li… - Biomedicine & …, 2024 - Elsevier
The RNA N 6-methyladenosine (m6A) regulator METTL3 is an important regulatory gene in
various progressive processes of prostate cancer (PCa). METTL3 inhibitors have been …
various progressive processes of prostate cancer (PCa). METTL3 inhibitors have been …
[HTML][HTML] The m6A regulators in prostate cancer: molecular basis and clinical perspective
Y Cao, M Jia, C Duan, Z Yang, B Cheng… - Frontiers in …, 2024 - frontiersin.org
Prostate cancer (PCa) is the second leading cause of cancer-related death among men in
western countries. Evidence has indicated the significant role of the androgen receptor (AR) …
western countries. Evidence has indicated the significant role of the androgen receptor (AR) …
[HTML][HTML] Epitranscriptomic mechanisms of androgen signalling and prostate cancer
R Patke, AE Harris, CL Woodcock, R Thompson… - Neoplasia, 2024 - Elsevier
Prostate cancer (PCa) is the second most common cancer diagnosed in men. While radical
prostatectomy and radiotherapy are often successful in treating localised disease, post …
prostatectomy and radiotherapy are often successful in treating localised disease, post …
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
L Yang, J Ying, Q Tao, Q Zhang - Nature Reviews Urology, 2024 - nature.com
Abstract The N6‐methyladenosine (m6A) modification is the most common modification of
messenger RNAs in eukaryotes and has crucial roles in multiple cancers, including in …
messenger RNAs in eukaryotes and has crucial roles in multiple cancers, including in …